AH Bio Fund II, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001725721. 10% Owner at Scribe Therapeutics, Inc. (SCTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in MENLO PARK, CA.
Companies AH Bio Fund II, L.P. has filed insider reports for
- Scribe Therapeutics, Inc. (SCTX): 10% Owner
AH Bio Fund II, L.P.
CIK: 0001725721
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SCTX
Scribe Therapeutics, Inc.
10% Owner